Yuan Meng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Systematic Review

Cell Cycle Arrest

Induced Apoptosis

Natural Killer Cells

Top Venues

Journal of leukocyte biology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yingge Lv, Hua Zhao, Shaochuan Liu, Yuan Meng, Wenwen Yu, Ting Liu, Qian Sun, Meng Shen, Xiubao Ren, Liang Liu
Anlotinib and anti-PD-1 mAbs perfected CIK cell therapy for lung adenocarcinoma in preclinical trials. Journal of leukocyte biology 116 (3) (2024)
Yingge Lv, Hua Zhao, Shaochuan Liu, Yuan Meng, Wenwen Yu, Ting Liu, Qian Sun, Meng Shen, Xiubao Ren, Liang Liu
Anlotinib and anti-PD-1 mAbs perfected CIK cell therapy for lung adenocarcinoma in preclinical trials. Journal of leukocyte biology (2024)
Yuan Meng, Yingge Lv, Meng Shen, Wenwen Yu, Yumeng Liu, Ting Liu, Gen Liu, Shiya Ma, Zhenzhen Hui, Xiubao Ren, Liang Liu
Establishment of an animal model of immune-related adverse events induced by immune checkpoint inhibitors. Cancer medicine 13 (14) (2024)
Lin Zhang, Yuan Meng, Yang An, Xuena Yang, Feng Wei, Xiubao Ren
The anti-tumor effect of extracellular vesicles derived from cytokine-activated CD8+ T cells. Journal of leukocyte biology (2024)
Yuan Meng, Yingge Lv, Meng Shen, Wenwen Yu, Yumeng Liu, Ting Liu, Gen Liu, Shiya Ma, Zhenzhen Hui, Xiubao Ren, Liang Liu
Establishment of an animal model of immune-related adverse events induced by immune checkpoint inhibitors. Cancer medicine 13 (14) (2024)